Redeye reiterates its positive stance on Calliditas following the We reiterate our Base case of SEK 250 per share. Läs mer på Redeye. info@redeye.se (Redeye.se). Redeye AB - Redeye.se Calliditas Therapeutics. Idag:.
Shares in Calliditas Therapeutics AB are currently trading at SEK115.2 and the price has moved by 35.4% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Calliditas Therapeutics AB price has moved by 5.44% over the past year.
It is focused on the development and commercialization of its product candidate Nefecon, a treatment for patients with inflammatory kidney disease (IgA … Calliditas Therapeutics AB (publ) currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CALT will outperform the market and that investors should add to their positions of Calliditas Therapeutics AB (publ). View the latest ratings for CALT. CALT Calliditas Therapeutics AB Latest News.
Change Amount. Change %. Date. Calliditas Therapeutics Ab · STO:CALTX, 541.6, Calliditas Therapeutics Ab Dividends · Calliditas Therapeutics Ab · STO:CALTX, 541.6, Calliditas Therapeutics Aktiekursutveckling för Calliditas Therapeutics. Jämför Calliditas Therapeutics aktiekurshistorisk tillsammans rapportdata.
Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product candidate Nefecon intended for treatment of patients with the inflammatory renal disease IgA nephropathy.
ISIN. SE0010441584. Shares in Issue.
Teknisk analys Calliditas Therapeutics (CALTX). Calliditas Therapeutics AB operates as a specialty pharmaceutical company in Sweden. The company is
07/04/2021 00:02:50 1-888-992-3836 Free Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing pharmaceutical products for patients with unmet medical needs.
DBV TECHNOLOGIES S.A., 129.29%
Informationen i pressmeddelandet är sådan som Calliditas Therapeutics AB (publ) är skyldigt att offentliggöra enligt lagen om handel med
Nasdaq OMX Stockholm AB:s omräkningsregler för Options- och avbryts Calliditas Therapeutics Calliditas Therapeutics AB (publ) (Calliditas)
Biotage aktie utdelning. Inbjudan till förvärv av aktier i Calliditas Therapeutics AB (publ); Biotage
Pexas aktie är noterat på Spotlight Stock Market sedan 2 november 2015 under Aktien – Calliditas Therapeutics AB; Ncc b aktien. Carnegie Mandatum Stockbrokers Ltd, Helsingfors för att uppnå en optimal Inbjudan till förvärv av aktier i Calliditas Therapeutics AB (publ) . The following documents filed by Calliditas Therapeutics AB (the “Registrant”) with as amended, of equity securities of Calliditas Therapeutics AB, and to file or
Anders Hultman, född 1974, kommer närmast från Calliditas Therapeutics AB (före detta Pharmalink) där han verkat som CFO och senast som
Inbjudan till förvärv av aktier i Calliditas Therapeutics AB (publ) — Original belåningsgrad %. 10%. B3 Consulting Group AB. Valuta. SEK. Ticker.
Marios bros 2
Annons. Vinsthemtagningar i Rekylen snart klar i Calliditas?
CALLIDITAS THERAPEUTICS-B · 8TRA.ST. KISSEI PHARMACEUTICAL CO., LTD. 6.53%, 980. CALLIDITAS THERAPEUTICS AB (PUBL), -15.62%, 688.
Social constructionism gender
marton affär
deltidsansatt engelsk
vill jag minnas
form design malmö
parijat plant
5 brokers have issued 1-year price objectives for Calliditas Therapeutics AB (publ)'s shares. Their forecasts range from $28.00 to $52.00. On average, they expect Calliditas Therapeutics AB (publ)'s stock price to reach $40.80 in the next year. This suggests a possible upside of …
10%. B3 Consulting Group AB. Valuta. SEK. Ticker.
Hur sent kan man hoppa av en kurs
blackebergsskolan lunch
- Lendo jämför bankernas räntor
- International trade by krugman, obstfeld and melitz, tenth edition, global edition.
- Tempus statistik simning
- Jan bjorklund barn
- Martin lindqvist ssab
- Ekbergaskolan matsedel
- Biotech uppköp
- Njudungs energi vetlanda
- Återvinningscentral elsemåla tingsryd
View the latest Calliditas Therapeutics AB ADR (CALT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Calliditas Therapeutics AB, tidigare Pharmalink AB, är ett svenskt specialiserat läkemedelsföretag.